Taysha Gene Therapies (TSHA) Revenue (2019 - 2026)
Taysha Gene Therapies (TSHA) revenue from Sep 30, 2019 to Mar 31, 2026. The TTM Taysha Gene Therapies (TSHA) revenue is $7.48M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Taysha Gene Therapies (TSHA) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +3.60% |
| 3 Years TTM | +1.23% |
Annual Revenue change of Taysha Gene Therapies (TSHA)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $0 | -100.00% |
| 2025 | $9.77M | +17.29% |
| 2024 | $8.33M | -46.08% |
| 2023 | $15M | +518.00% |
| 2022 | $2.50M | N/A |
| 2021 | $0 | N/A |
| 2020 | $0 | N/A |
| 2019 | $0 | N/A |